Search Results - "Ferrand, Francois Regis"

Refine Results
  1. 1

    Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challenges by Baloche, Valentin, Ferrand, François-Régis, Makowska, Anna, Even, Caroline, Kontny, Udo, Busson, Pierre

    Published in Expert opinion on therapeutic targets (02-06-2020)
    “…: Nasopharyngeal carcinoma (NPC) is a major public health problem in several countries, especially those in Southeast Asia and North Africa. In its typical…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Precision Postoperative Radiotherapy in Sinonasal Carcinomas after Endonasal Endoscopic Surgery by Thariat, Juliette, Carsuzaa, Florent, Marcy, Pierre Yves, Verillaud, Benjamin, de Gabory, Ludovic, Ferrand, Francois Regis

    Published in Cancers (25-09-2021)
    “…Radiotherapy plays an important role in the treatment of sinonasal cancer, mainly in the adjuvant setting after surgical resection. Many technological…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Disseminated intravascular coagulation in solid tumours by Ferrand, François Régis, Garcia-Hejl, Carine, Moussaid, Yassine, Schernberg, Antoine, Bidard, François-Clément, Pavic, Michel, Khenifer, Safia, Stoclin, Annabelle

    Published in Bulletin du cancer (01-06-2014)
    “…Disseminated intravascular coagulation (DIC) is a complex abnormality of hemostasis with dramatic consequences and long described as associated with tumors…”
    Get more information
    Journal Article
  12. 12

    Disseminated and circulating tumor cells in gastrointestinal oncology by Vegas, Hélène, André, Thierry, Bidard, François-Clément, Ferrand, François-Régis, Huguet, Florence, Mariani, Pascale, Pierga, Jean-Yves

    Published in Bulletin du cancer (01-05-2012)
    “…Circulating (CTC) and disseminated tumor cells (DTC) represent two different steps of the metastatic process. As with other types of cancer, the recent…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary results by Daoudi, Hannah, Labeyrie, Marc A., Guillerm, Sophie, Delanian, Sylvie, Guichard, Jean‐Pierre, Jourdaine, Clément, Faivre, Sandrine, Gauthier, Helene, Ferrand, FrançoisRégis, Verillaud, Benjamin, Herman, Philippe

    Published in Laryngoscope investigative otolaryngology (01-02-2020)
    “…Objective Osteoradionecrosis (ORN) of the sphenoid is a rare but potentially lethal complication that can occur after irradiation of nasopharyngeal and clival…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial by Guigay, Joël, Fayette, Jérôme, Saada-Bouzid, Esma, Martin, Laurent, Capitain, Olivier, Castanie, Hélène, Vansteene, Damien, Schafhausen, Philippe, Johnson, Alison, Even, Caroline, Duplomb, Sophie, Evrard, Camille, Laguerre, Brigitte, Chevassus-Clément, Cécile, Sinigaglia, Laura, Keilholz, Ulrich, Bourhis, Jean, Mesia, Ricard, BABA-HAMED, Nabil, BABIN, Emmanuel, BERA, Guillaume, BETRIAN-LAGARDE, Sarah, BLOT, Emmanuel, BOREL, Christian, BRUYAS, Amandine, CALAIS, Gilles, CARPIUC, Ioana, CHAPET, Sophie, CHATELLIER, Thierry, CHELI, Sandrine, CLATOT, Florian, COJOCARASU, Oana, COUTTE, Alexandre, DALLOZ, Pierre, DELHOMMEAU, Melissa, DE RAUCOURT, Dominique, DEBOURDEAU, Philippe, DUBOS-ARVIS, Catherine, DUCOULOMBIER, Agnès, EL KOURI, Claude, FALKOWSKI, Sabrina, FERRAND, François-Regis, GATINEAU, Michel, GERVAIS, Radj, GRAS, Louis, HASBINI, Ali, HENAULT, Stéphane, HERRERA GOMEZ, Ruth Gabriela, HUGUET, Florence, LAGRANGE, Aurélie, LE FOLL, Christine, LINOT, Benjamin, LOPEZ, Qian, MAYACHE-BADIS, Lamia, MINNE, Floriane, NEIDHARDT, Eve Marie, PAVILLET, Julien, PEYRADE, Frédéric, POINTREAU, Yohann, RAMEE, Jean-François, RAUCHE, Camille, RICHARD, Sandrine, RIZZO, Claudia, ROLLAND, Frédéric, STEFANI, Laetitia, THERY, Jean-Christophe, TOULLEC, Clémence, TOURANI, Jean-Marc, TOUSSAINT, Philippe, VAULEON, Elodie, VIRET, Frédéric, WALER, Sabine, ATZPODIEN, Jens, FIETKAU, Rainer, GRANIZKA, Thordis, GUNTINAS-LICHINUS, Orlando, HADLER-MIKESCH, Kristina, HAHN, Dennis, INHESTERN, Johanna, KELLNER, Karolin, KLINGHAMMER, Konrad, KRONENBERGER, Roland, LUEDTKE-HECKENKAMP, Kerstin, PIRLICH, Markus, ROTHMANN, Frank, TOMETTEN, Mareike, WOHLFARTH, Sabine, ZEBRALLA, Veit, ZIPFEL, Matthias, ADANSA KLEIN, Juan Carlos, ARRAZUBI, Virginia, CABALLERO DAROQUI, Javier, CASTELO, Beatriz, GALLEGO, Oscar, IGLESIAS DOCAMPO, Lara Carmen, MARTINEZ DEL PRADO, Maria, MARTINEZ-TRUFERO, Javier, PASTOR BORGONON, Miguel, PEREZ RUIZ, Elisabeth, RUBIO CASADEVALL, Jordi

    Published in The lancet oncology (01-04-2021)
    “…Results from a phase 2 trial of the TPEx chemotherapy regimen (docetaxel–platinum–cetuximab) showed promising results, with a median overall survival of 14·0…”
    Get full text
    Journal Article